Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

US Patent 7842501 · Granted Nov 30, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Layered bimetallic hydroxide-based hydrogel bipolar membrane and method for prep2025
Equal dispersion split-flow mixer2025
Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor2025
Antibody-TNF α fusion protein and its preparation and applications2025
Drug combination containing TLR7 agonist2025
Wheel hub cap2025
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2025
Rubber jack pad2025
Bottle jack saddle axle adapter2025
Rubber jack pad2025
Anti-coronavirus antibodies and methods of use2024
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2024